newsfilter
← Latest News
GlobeNewswire·

Annovis Achieves Significant Milestones and Sustains Strong Progress in Phase 3 Alzheimer's Program

All 84 clinical sites across the U.S. are fully activated, enrolling, and treating patients The first group of participants reached the 6-month treatment milestone The study is now 25% complete, keeping Annovis on